Linked Data API

Show Search Form

Search Results

1137940
registered interest false more like this
date less than 2019-07-09more like thismore than 2019-07-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Health Services and Social Services: Data Protection more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government what plans they have, if any, to permit anonymised data (1) controlled, or (2) generated, by publicly funded health and care organisations in the UK to be shared for commercial purposes with businesses headquartered in non-EEA countries after Brexit. more like this
tabling member printed
Lord Freyberg more like this
uin HL17039 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-17more like thismore than 2019-07-17
answer text <p>Access to patient information for commercial purposes is not permitted, unless the patient has given their consent. The Government's principles governing data-sharing agreements entered into by National Health Service organisations, originally published in draft in December 2018 and reaffirmed in the policy framework update document published earlier this month, make clear that NHS data may only be accessed by third parties where there is an explicit aim to improve the health, welfare and/or care of patients in the NHS or the operation of the NHS, and that a fair share of the benefits from any agreements flow back to the NHS. We do not anticipate this will change when the United Kingdom leaves the European Union.</p><p> </p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-07-17T14:08:20.8Zmore like thismore than 2019-07-17T14:08:20.8Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2593
label Biography information for Lord Freyberg more like this
1137951
registered interest false more like this
date less than 2019-07-09more like thismore than 2019-07-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Life Expectancy more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government what assessment they have made of why the UK had one of the largest slowdowns in improvements in life expectancy between 2011 and 2016 out of the 19 countries analysed by the Office for National Statistics in August 2018. more like this
tabling member printed
Lord Mendelsohn more like this
uin HL17050 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-17more like thismore than 2019-07-17
answer text <p>Life expectancy is as high as it has ever been in this country, but the rate of increase in life expectancy has slowed down in recent years. To better understand the reasons for the slowdown, the Department commissioned Public Health England to publish <em>A review of recent trends in mortality in England</em>, which includes comparison to other parts of the United Kingdom, the European Union and United States of America. A copy of the review is attached.</p><p>The overall slowdown in improvements is due to a range of factors operating simultaneously across a wide range of age groups, places, and causes of death. Issues include:</p><p> </p><p>- the slowdown in improvement in mortality from heart disease and stroke, which are the leading causes of death. This is partly influenced by the increasing prevalence of diabetes, obesity, and low physical activity;</p><p>- the size and frequency of recent winter peaks in mortality, which were influenced by the intensity and dominant type of influenza circulating, flu vaccine uptake and effectiveness, and is sometimes exacerbated by cold weather, especially among the very elderly people living with conditions such as dementia. Housing and fuel poverty are key to cold weather vulnerability;</p><p>- in younger adults, the cause of death that had the biggest impact was accidental poisoning, a large proportion of these deaths are due to drug misuse; and</p><p>- small increases in mortality rates from chronic lower respiratory disease in males and females, and other causes in males (including cirrhosis and other liver diseases).</p><p> </p><p>The Government remains committed to giving people five extra years of healthy, independent life by 2035 and to ensuring that everyone gets the same great healthcare no matter where they live, backed by our Long Term Plan for the National Health Service.</p>
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-07-17T13:35:13.033Zmore like thismore than 2019-07-17T13:35:13.033Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
attachment
1
file name Recent_trends_in_mortality_in_England.pdf more like this
title A review of recent trends in mortality in England more like this
tabling member
4286
label Biography information for Lord Mendelsohn more like this
1137952
registered interest false more like this
date less than 2019-07-09more like thismore than 2019-07-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Mortality Rates: Boys more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government what assessment they have made of the finding of the Office for National Statistics in its mid-year population estimates published in June, that there has been a 14 per cent annual increase in the rate of mortality of boys aged five to nine. more like this
tabling member printed
Lord Mendelsohn more like this
uin HL17051 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-17more like thismore than 2019-07-17
answer text <p>The Office for National Statistics data shows that for boys aged five to nine there were 137 deaths in England in the period mid-2017 to mid-2018. This is an increase of 19 deaths compared with the period mid-2016 to mid-2017, when there were 118 deaths. As the number of deaths fluctuate between individual years, a longer period must be looked at for evidence of trends. Public Health England’s review of recent trends in mortality in England, showed that there was an improvement in mortality rates for children aged five to nine between 2011 and 2016. There was also an improvement in early periods, 2001 to 2006, and 2006 to 2011.</p><p>Improving child health outcomes is central to the NHS Long Term Plan and for prioritising services for children and young people. It provides a clear focus on improving the health of children and young people across mental health, learning disabilities, cancer and elsewhere.<strong> </strong></p><p> </p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-07-17T13:33:57.147Zmore like thismore than 2019-07-17T13:33:57.147Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
4286
label Biography information for Lord Mendelsohn more like this
1137956
registered interest false more like this
date less than 2019-07-09more like thismore than 2019-07-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Speech and Language Therapy: Children more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government whether the Secretaries of State for Health and Social Care, Education, and Housing, Communities and Local Government have discussed, or plan to discuss the findings of the Children's Commissioner for England's report We need to talk: Access to speech and language therapy, published on 11 June. more like this
tabling member printed
Lord Ramsbotham more like this
uin HL17055 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-17more like thismore than 2019-07-17
answer text <p>Colleagues across different Departments meet frequently to discuss a range of topics relating to child wellbeing. The Government recognises that speech, language and communication skills are a primary indicator of child wellbeing and will continue to provide strategic leadership across education, health and social care to narrow inequalities.</p><p> </p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-07-17T14:09:03.02Zmore like thismore than 2019-07-17T14:09:03.02Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
3744
label Biography information for Lord Ramsbotham more like this
1137390
registered interest false more like this
date less than 2019-07-08more like thismore than 2019-07-08
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Lumacaftor/ivacaftor more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government whether a date has been set for Vertex pharmaceuticals, NICE and NHS England to convene a further meeting to discuss how the cystic fibrosis drug Orkambi can be made available to patients. more like this
tabling member printed
Baroness Morgan of Huyton more like this
uin HL16997 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-15more like thismore than 2019-07-15
answer text <p>NHS England and NHS Improvement is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients. No date has been agreed for a further meeting as of yet, however negotiations are ongoing between Vertex, NHS England and NHS Improvement and NICE.</p><p>Cystic fibrosis can have a devastating effect on the lives of those who suffer from it, and those close to them, and the Government wants to see patients access innovative treatments at a cost-effective price for the NHS. The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p>
answering member printed Baroness Blackwood of North Oxford more like this
grouped question UIN
HL16998 more like this
HL16999 more like this
question first answered
less than 2019-07-15T10:23:54.303Zmore like thismore than 2019-07-15T10:23:54.303Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2168
label Biography information for Baroness Morgan of Huyton more like this
1137391
registered interest false more like this
date less than 2019-07-08more like thismore than 2019-07-08
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Lumacaftor/ivacaftor more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government what assessment they have made of the impact of the lack of availability of Orkambi on patients with cystic fibrosis; and what plans they have to discuss this issue with (1) patients, and (2) other interested parties. more like this
tabling member printed
Baroness Morgan of Huyton more like this
uin HL16998 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-15more like thismore than 2019-07-15
answer text <p>NHS England and NHS Improvement is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients. No date has been agreed for a further meeting as of yet, however negotiations are ongoing between Vertex, NHS England and NHS Improvement and NICE.</p><p>Cystic fibrosis can have a devastating effect on the lives of those who suffer from it, and those close to them, and the Government wants to see patients access innovative treatments at a cost-effective price for the NHS. The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p>
answering member printed Baroness Blackwood of North Oxford more like this
grouped question UIN
HL16997 more like this
HL16999 more like this
question first answered
less than 2019-07-15T10:23:54.243Zmore like thismore than 2019-07-15T10:23:54.243Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2168
label Biography information for Baroness Morgan of Huyton more like this
1137392
registered interest false more like this
date less than 2019-07-08more like thismore than 2019-07-08
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Lumacaftor/ivacaftor more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government what plans the Secretary of State for Health and Social Care has to intervene in the ongoing negotiations between Vertex pharmaceuticals, NICE and NHS England on the price of the cystic fibrosis drug Orkambi to ensure that it is made available to patients as soon as possible. more like this
tabling member printed
Baroness Morgan of Huyton more like this
uin HL16999 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-15more like thismore than 2019-07-15
answer text <p>NHS England and NHS Improvement is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients. No date has been agreed for a further meeting as of yet, however negotiations are ongoing between Vertex, NHS England and NHS Improvement and NICE.</p><p>Cystic fibrosis can have a devastating effect on the lives of those who suffer from it, and those close to them, and the Government wants to see patients access innovative treatments at a cost-effective price for the NHS. The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p>
answering member printed Baroness Blackwood of North Oxford more like this
grouped question UIN
HL16997 more like this
HL16998 more like this
question first answered
less than 2019-07-15T10:23:54.35Zmore like thismore than 2019-07-15T10:23:54.35Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2168
label Biography information for Baroness Morgan of Huyton more like this
1137071
registered interest false more like this
date less than 2019-07-04more like thismore than 2019-07-04
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Human Embryo Experiments: Regulation more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government, further to the Written Answer by Earl Howe on 9 October 2013 (HL2237), what assessment the Scientific and Clinical Advances Advisory Committee of the Human Fertilisation and Embryology Authority has made of the regulation of embryoid bodies following the publication of research (1) by Lancaster et al. Cerebral organoids model human brain development and microcephaly in 2013, and (2) in the Nature Cell Biology journal A 3D model of a human epiblast reveals BMP4-driven symmetry breaking on 1 July. more like this
tabling member printed
Lord Alton of Liverpool more like this
uin HL16935 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-17more like thismore than 2019-07-17
answer text <p>The Scientific and Clinical Advances Advisory Committee of the Human Fertilisation and Embryology Authority has made no formal assessment of the regulation of embryoid bodies following the publication of research by Lancaster et al. <em>Cerebral organoids model human brain development and microcephaly</em> in 2013, and in the Nature Cell Biology journal <em>A 3D model of a human epiblast reveals BMP4-driven symmetry breaking</em> on 1 July. The publications will be brought to the attention of the Committee.</p><p> </p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-07-17T14:17:06.443Zmore like thismore than 2019-07-17T14:17:06.443Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
738
label Biography information for Lord Alton of Liverpool more like this
1137079
registered interest false more like this
date less than 2019-07-04more like thismore than 2019-07-04
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Care Homes: Dental Services more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government what assessment they have made of the report by the Care Quality Commission Smiling matters: oral health care in care homes, published on 24 June; and how they intend to respond. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL16943 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-17more like thismore than 2019-07-17
answer text <p>The Government welcomes the report by the Care Quality Commission <em>Smiling matters: oral health care in care homes</em>. The Department together with Public Health England, NHS England and Health Education England is carefully considering the recommendations made in the report and will respond in due course.</p><p>This consideration includes the recommendations that NHS England work with partners in the health and care system to improve access both to high street and, where required domiciliary care for residents of care homes. As well as the recommendation that both local and national monitoring frameworks should include awareness and assessment of oral health including the National Institute of Health and Care Excellence guideline NG48.</p><p>NHS England is responsible for commissioning primary care dental services, including domiciliary care. Domiciliary care may be delivered by any dentist holding a contract to deliver general dental services or it may be specifically commissioned by NHS England locally as an additional service. Where such services have been specifically commissioned any concerns about delivery should be raised with NHS England. NHS England has a duty to provide services to meet local need, including domiciliary services.</p>
answering member printed Baroness Blackwood of North Oxford more like this
grouped question UIN
HL16944 more like this
HL16945 more like this
HL16946 more like this
question first answered
less than 2019-07-17T14:11:41.61Zmore like thismore than 2019-07-17T14:11:41.61Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1137080
registered interest false more like this
date less than 2019-07-04more like thismore than 2019-07-04
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Care Homes: Dental Services more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government what steps they are taking to ensure that access to dental provision in care homes is improved. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL16944 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-17more like thismore than 2019-07-17
answer text <p>The Government welcomes the report by the Care Quality Commission <em>Smiling matters: oral health care in care homes</em>. The Department together with Public Health England, NHS England and Health Education England is carefully considering the recommendations made in the report and will respond in due course.</p><p>This consideration includes the recommendations that NHS England work with partners in the health and care system to improve access both to high street and, where required domiciliary care for residents of care homes. As well as the recommendation that both local and national monitoring frameworks should include awareness and assessment of oral health including the National Institute of Health and Care Excellence guideline NG48.</p><p>NHS England is responsible for commissioning primary care dental services, including domiciliary care. Domiciliary care may be delivered by any dentist holding a contract to deliver general dental services or it may be specifically commissioned by NHS England locally as an additional service. Where such services have been specifically commissioned any concerns about delivery should be raised with NHS England. NHS England has a duty to provide services to meet local need, including domiciliary services.</p>
answering member printed Baroness Blackwood of North Oxford more like this
grouped question UIN
HL16943 more like this
HL16945 more like this
HL16946 more like this
question first answered
less than 2019-07-17T14:11:41.657Zmore like thismore than 2019-07-17T14:11:41.657Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this